Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-20-049618

SVP, Finance and CFO sold 15,004 shares at $50.91 ($763,854)

  • SVP, Finance and CFO acquired 15,004 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cotroneo Pat · SVP, Finance and CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-03 Exercise or conversion : show line 1 in the form +637 $29.66 $18,893 278,947 D
2020-09-03 Exercise or conversion : show line 2 in the form +5,696 $19.39 $110,445 284,643 D
2020-09-03 Exercise or conversion : show line 3 in the form +8,671 $25.40 $220,243 293,314 D
2020-09-03 Sale : show line 4 in the form −15,004 $50.91 $763,854 278,310 D
Open-market sales · 15,004 sh · avg $50.91 · $763,854

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-03 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −637 $29.66 2025-03-04 637 4,618 D
2020-09-03 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,696 $19.39 2026-02-22 5,696 0 D
2020-09-03 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −8,671 $25.40 2027-03-08 8,671 41,579 D
Loading xslF345X03/doc4.xml…